Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names

In This Article:

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

The earnings figure itself is key, but a beat or miss on the bottom line can sometimes be just as, if not more, important. Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb even higher.

2 Stocks to Add to Your Watchlist

The Zacks Earnings ESP, or Expected Surprise Prediction, aims to find earnings surprises by focusing on the most recent analyst revisions. The basic premise is that if an analyst reevaluates their earnings estimate ahead of an earnings release, it means they likely have new information that could possibly be more accurate. The core of the ESP model is comparing the Most Accurate Estimate to the Zacks Consensus Estimate, where the resulting percentage difference between the two equals the Expected Surprise Prediction.

The final step today is to look at a stock that meets our ESP qualifications. Elevance Health (ELV) earns a Zacks Rank #3 19 days from its next quarterly earnings release on April 22, 2025, and its Most Accurate Estimate comes in at $11.47 a share.

Elevance Health's Earnings ESP sits at 5.06%, which, as explained above, is calculated by taking the percentage difference between the $11.47 Most Accurate Estimate and the Zacks Consensus Estimate of $10.92.

ELV is part of a big group of Medical stocks that boast a positive ESP, and investors may want to take a look at Organon (OGN) as well.

Slated to report earnings on May 1, 2025, Organon holds a #3 (Hold) ranking on the Zacks Rank, and it's Most Accurate Estimate is $0.94 a share 28 days from its next quarterly update.

The Zacks Consensus Estimate for Organon is $0.92, and when you take the percentage difference between that number and its Most Accurate Estimate, you get the Earnings ESP figure of 1.81%.

ELV and OGN's positive ESP metrics may signal that a positive earnings surprise for both stocks is on the horizon.

Find Stocks to Buy or Sell Before They're Reported

Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Elevance Health, Inc. (ELV) : Free Stock Analysis Report